§ BIOTECHNOLOGY
USD · Biotechnology

ARWR

ARROWHEAD PHARMACEUTICALS IN
USDSector · BiotechnologyBeta · 1.24
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
291 increased/new, 156 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E42.3P/B10.04
EPS (TTM)1.54
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.18.2M0.0%−15%
Avoro Capital Advisors LLC10.7M6.6%n/a
Fidelity Management7.3M0.0%+11%
VANGUARD PORTFOLIO MANAGEMENT LLC7.1Mn/an/a
State Street6.5M0.0%+1%
VANGUARD CAPITAL MANAGEMENT LLC6.0Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for ARWR as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER6.4% · 0 holders
OTHER44.0% · 319 holders
PASSIVE / INDEX19.9% · 11 holders
QUALITY / COMPOUNDER13.1% · 29 holders
DEALER / BANK12.3% · 38 holders
INCOME / DEFENSIVE1.5% · 27 holders
SYSTEMATIC / QUANT1.4% · 9 holders
ACTIVIST0.9% · 1 holder
TACTICAL / MACRO0.5% · 5 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for ARWR in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention ARWR yet.